Mammalian Diaphanous-related formin (mDia)

Mammalian Diaphanous-related formins (mDia) are a family of three proteins—mDia1 (DIAPH1), mDia2 (DIAPH3), and mDia3 (DIAPH2)—that function as essential regulators of the actin cytoskeleton [UniProt]. They are characterized by their Formin Homology 2 (FH2) domains, which directly nucleate and elongate unbranched actin filaments [PubMed: 10436159]. As downstream effectors of Rho-family GTPases like RhoA, mDia proteins are activated when the GTPase binds to the Diaphanous Inhibitory Domain (DID), releasing the protein from its autoinhibited state [PubMed: 23230154]. These proteins play pivotal roles in fundamental cellular processes such as cytokinesis, cell migration, and vesicle trafficking [PubMed: 25103138]. In cancer, dysregulation of mDia isoforms is associated with increased tumor cell invasion and the production of large oncosomes, which are extracellular vesicles linked to aggressive disease [PubMed: 19447838]. Mutations in the genes encoding these formins are also linked to human diseases, including non-syndromic hearing loss (DIAPH1) and microcephaly (DIAPH3) [PubMed: 25103138]. While small molecule inhibitors like SMIFH2 have been developed to target the FH2 domain, their lack of specificity across the formin family remains a challenge [PubMed: 19249256]. More specific modulators, such as the IMM series of compounds, are being investigated for their potential to selectively tune mDia activity in therapeutic contexts [PubMed: 26166574]. Despite their therapeutic potential in cancer and fibrosis, the requirement of mDia for normal cell division necessitates careful evaluation of systemic toxicity [PubMed: 23230154]. Overall, mDia formins represent a significant class of cytoskeletal targets with broad implications in both developmental biology and chronic disease management.

Other names

DIAPHDiaphanous-related forminmDia1mDia2mDia3Protein diaphanous homolog

Inhibition of the Formin Homology 2 (FH2) domain to prevent actin filament nucleation and elongation, or stabilization of the autoinhibited state via the DAD-DID interaction.